HLF Options Signal Unusual Bullishness Ahead of Q3 Print

Herbalife heads into its November 4 earnings release with options traders positioned at the most bullish extreme in a year, a sharp contrast to the steady short interest overhead that has defined the stock for months.

The clearest signal heading into the print is in options. The put/call ratio collapsed to 0.46 on Monday, more than four standard deviations below its 20-day average of 0.75. That is the lowest reading in the past year, well beneath even the previous 52-week low of 0.32, and it marks a dramatic break from a long stretch where the PCR barely moved from the 0.75 to 0.78 range. Call buying has surged relative to put protection, suggesting a cohort of options traders is positioning for a sharp move higher on the release rather than hedging against downside.

The short side tells a more complicated story. At 7.8% of free float, short interest is meaningful and has been a persistent feature of HLF for years. But shorts have been covering steadily: the position is down roughly 11% over the past month and nearly 5% over the past week alone, pulling from above 9 million shares in early October to around 8 million now. Borrow conditions offer no signal of squeeze pressure. The cost to borrow is a negligible 0.53%, and availability is running at 514% of short interest, meaning lenders hold roughly six shares available for every one currently shorted. There is plenty of room for shorts to rebuild if the print disappoints.

The bull and bear debate on Herbalife centres on whether the company is genuinely stabilising after years of distributor network attrition, or simply bouncing along a depressed floor. Bulls can point to a trailing PE of around 4.5 and an EV/EBITDA of roughly 4.5, valuation levels that rank in the 99th percentile on earnings yield and EV/EBIT metrics, meaning the stock is priced for very little recovery at all. Citigroup maintains a Buy with a $17 target, implying nearly 28% upside from the current $13.28. Bears focus on persistent top-line pressure, a negative book value, and the COO's open-market sale of roughly $620,000 in stock in May, the most recent meaningful insider transaction. The ORTEX short score of 55.8 reflects a moderately elevated bearish consensus that has, however, been edging lower through October as positions covered.

The ownership picture adds texture. Baupost Group holds 8.8% and has not changed its position in recent quarters, a steady hand from a value-oriented manager known for patient, concentrated bets. Route One Investment, another concentrated value fund, holds 7.97% and added shares through the first half. BlackRock added 549,000 shares in the quarter ended September, a more recent endorsement. Against that, Renaissance Technologies trimmed its position to just below 5%, crossing below the threshold that would require another 13G disclosure.

The November 4 print will test whether the cost structure and distributor metrics can support even the undemanding earnings trajectory currently implied by the stock's multiple, and whether the unusual burst of call-side optimism in the options market is prescient or premature.